in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
AMRI awarded development and manufacturing contract by UK government
10:06 AM MDT | September 30, 2013 | Deepti Ramesh
Albany Molecular Research Inc. (AMRI; Albany, NY) says that its wholly owned Albany Molecular Research UK (Holywell, UK) subsidiary has been awarded a seven-year contract for the development and manufacture of an active ingredient under clinical evaluation. The contract was awarded by the Defense Science and Technology Laboratory (Salisbury, UK) acting on behalf of the UK secretary of state for defense, the Department of National Defence of Canada (Ottawa), and minister of defense of the Netherlands. AMRI will initially work on the development and scale-up of the...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee